研究成果 (117)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/5

A B C D E F G H I L M N O P Q R S T V W 針全部

Adjuvant S-1 chemotherapy after curative resection of gastric cancer (Author's reply)
Winnie Yeo, KO Lam, Ada LY Law, CL Chiang, Conrad CY Lee, KH Au ( 2017 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.12809/hkmj176283
Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors
Yeo W, Lam KO, Law AL, Lee CC, Chiang CL, Au KH, Mo FK, So TH, Lam KC, Ng WT, Li L ( 2017 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.12809/hkmj164885
Afatinib versus Gefitinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients Aged ≥75 Years: Subgroup Analysis of LUX-Lung 7
Keunchil Park, Eng Huat Tan, Li Zhang, Vera Hirsh, Ken O’Byrne, Michael Boyer, James Chih-Hsin Yang, Tony Mok, Barbara Peil, Angela Märten, Luis Paz-Ares ( 2017 )
Invited conference paper presented and published in conference proceedings
A feasibility study to evaluate the relationships between endocrine symptoms, drug adherence and genetic polymorphisms in breast cancer patients receiving tamoxifen therapy
Chan C. W. H., Chow K. M., McCarthy A., Chan J. Y. W., Waye M. M. Y., Tsui S. K. W., Yeo W., Choi K. C., So W. K. W., Soo W., Miaskowski C. ( 2017 )
Other outputs
A feasibility study to evaluate the relationships between endocrine symptoms, drug adherence and genetic polymorphisms in breast cancer patients receiving tamoxifen therapy
Chan C. W. H., McCarthy A., Chan J. Y. W., Waye M. M. Y., Tsui S. K. W., Yeo W., Choi K. C., So W. K. W., Soo W., Miaskowski C. ( 2017 )
Other conference paper
Alectinib versus crizotinib in treatment-naive advanced ALK-positive non-small cell lung cancer (NSCLC): Primary results of the global phase III ALEX study.
Alice Tsang Shaw, Solange Peters, Tony Mok, Shirish M. Gadgeel, Jin Seok Ahn, Sai-Hong Ignatius Ou, Maurice Perol, Rafal Dziadziuszko, Dong-Wan Kim, Rafael Rosell, Ali Hassan Zeaiter, Ting Liu, Sophie Golding, Bogdana Balas, Johannes Noé, Peter N. Morcos, D. Ross Camidge ( 2017 )
Invited conference paper presented and published in conference proceedings
典藏於此文庫的全文:
file.pdf
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer
Solange Peters, D. Ross Camidge, Alice T. Shaw, Shirish Gadgeel, Jin S. Ahn, Dong-Wan Kim, Sai-Hong I. Ou, Maurice Pérol, Rafal Dziadziuszko, Rafael Rosell, Ali Zeaiter, Emmanuel Mitry, Sophie Golding, Bogdana Balas, Johannes Noe, Peter N. Morcos, Tony Mok, for the ALEX Trial Investigators ( 2017 )
Publication in refereed journal
典藏於此文庫的全文:
nejmoa1704795.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1056/NEJMoa1704795
A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)
Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheung ACK, Ng WT, Lee VHF, Ma B, Cheng HC, Wong CS, Loong HHF, Tong M, Poon DMC, Ahuja A, King AD, Wang K, Mo F, Zee BCY, Chan AKC, Lo DYM ( 2017 )
Refereed conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.6002
Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
K.C. Allen Chan, John K.S. Woo, Ann King, Benny C.Y. Zee, W.K. Jacky Lam, Stephen L. Chan, Sam W.I. Chu, Constance Mak, Irene O.L. Tse, Samantha Y.M. Leung, Gloria Chan, Edwin P. Hui, Brigette B.Y. Ma, Rossa W.K. Chiu, Sing-Fai Leung, Andrew C. van Hasselt, Anthony T.C. Chan, Y.M. Dennis Lo ( 2017 )
The New England journal of medicine
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1056/NEJMoa1701717
A novel and validated inflammation-integrated prognostic model for hepatocellular carcinoma (HCC)
Chan AWH, Chong CCN, Lai PBS, Yeo W, To KF, Chan SL ( 2017 )
JOURNAL OF CLINICAL ONCOLOGY
Other outputs
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e15679
Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
Chen LT, Oh DY, Ryu MH, Yeh KH, Yeo W, Carlesi R, Cheng R, Kim J, Orlando M, Kang YK ( 2017 )
Publication in refereed journal
典藏於此文庫的全文:
Anti-angiogenic Therapy in Patients with Advanced Gastric.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.4143/crt.2016.176
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma
Stephen L. Chan, Winnie Yeo, Frankie Mo, Anthony W.H. Chan, Jane Koh, Leung Li, Edwin P. Hui, Charing C.N. Chong, Paul B.S Lai, Tony S.K. Mok, Simon C.H. Yu ( 2017 )
Cancer
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1002/cncr.30825
A Phase I/II study everolimus in combination with paclitaxelcarboplatin in patients with advanced adenocarcinoma of the stomach. Annals of Oncology 2017, #402P
H.H. Loong, F. Mo, L. Li, C. Lee, K-C. Lam, J. Koh, P. Chiu, A. Teoh, A.T.C. Chan, E. Ng, W. Yeo ( 2017 )
Refereed conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdx367.035
A phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer
Brigette Ma, Janet Lee, Michael Cheung, Simon Chu, Dennis CK Ng, Li Leung, Carmen Cho, Esther HY Hung, William WK Yeung, Macy Tong, Wing M Ho, Edwin P Hui, Wai K Tsang, Sophie Hon, Tony Mak, Simon SM Ng, Joyce Suen ( 2017 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdx261.363
A preclinical study of the combined treatment of arginase and canavanine in pancreatic cancer
TT Kwong, CH Wong, HH Loong, Stephen L Chan ( 2017 )
Refereed conference paper presented and published in conference proceedings
A randomised control clinical trial to assess the impact of enhanced geriatric input on elderly patients undergoing colorectal cancer surgery
T. Mak, D. Dai, J. Lee, B. Ma, W. Leung, S. Ng ( 2017 )
Other conference paper
A randomized controlled trial to assess the impact of enhanced geriatric input on elderly patients undergoing colorectal cancer surgery
HO MF, Dai DL, Lee JF, Ma B, Leung WW, NG SS, Mak TW ( 2017 )
Invited conference paper presented and published in conference proceedings
Baseline frequency of brain metastases and outcomes with multikinase inhibitor therapy in patients with RET-rearranged lung cancers
Alexander E. Drilon, Thomas Filleron, Isabella Bergagnini, Julie Milia, Vaios Hatzoglou, Vamsidhar Velcheti, Benjamin Besse, Tony Mok, Mark M. Awad, Juergen Wolf, David P. Carbone, D. Ross Camidge, Gregory J. Riely, Nir Peled, Julien Mazieres, Mark G. Kris, Oliver Gautschi, Global Multicenter RET Registry Investigators ( 2017 )
Invited conference paper presented and published in conference proceedings
典藏於此文庫的全文:
file.pdf
BCLB, methylated in hepatocellular carcinoma, is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascade
Liu XL, Hu XT, Kuang YY, Yan PJ, Li LL, Li C, Tao Q, Cai XJ ( 2017 )
CANCER LETTERS
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.canlet.2017.02.030
Biomarker analysis of the multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)
Edwin Pun Hui, Anthony T. C. Chan, Roger K.C. Ngan, Stewart Yuk Tung, Ashley Chi Kin Cheng, Wai Tong Ng, Victor HF Lee, Brigette Ma, Hoi Ching Cheng, Frank C.S. Wong, Herbert H. F. Loong, Macy Tong, Daren MC Poon, Anil Tejbhan Ahuja, Ann Dorothy King, Ki Wang, Frankie Mo, Benny C.Y. Zee, Allen K.C. Chan, YM Dennis Lo ( 2017 )
Refereed conference paper presented and published in conference proceedings
CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of ID and neuroblastoma cell differentiation
Xuan Li, Xiao-Qi Wu, Rong Deng, Dan-Dan Li, Jun Tang, Wen-Dan Chen, Jing-Hong Chen, Jiao Ji, Lin Jiao, Shan Jiang, Fen Yang, Gong-Kan Feng, Ravichandran Senthilkumar, Fei Yue, Hai-Liang Zhang, Rui-Yan Wu, Yan Yu, Xue-Lian Xu, Jia Mai, Zhi-Ling Li, Xiao-Dan Peng, Yun Huang, Xiang Huang, Ning-Fang Ma, Qian Tao, Yi-Xin Zeng, Xiao-Feng Zhu ( 2017 )
Publication in refereed journal
典藏於此文庫的全文:
64713791.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1038/s41467-017-01272-2
Ceritinib plus nivolumab (NIVO) in patients (pts) with anaplastic lymphoma kinase positive (ALK+) advanced non-small cell lung cancer (NSCLC)
Enriqueta Felip, Filippo G De Braud, Michela Maur, Herbert HF Loong, Alice Tsang Shaw, Johan F Vansteenkiste, Tom John, Geoffrey Liu, Martijn P Lolkema, Jeffrey W Scott, Richard Yu, Giovanni Selvaggi, Kaushal Mishra, Yi-Yang Yvonne Lau, Daniel Shao-Weng Tan ( 2017 )
Invited conference paper presented and published in conference proceedings
Change in Practice Patterns from an Online NSCLC Treatment Decision Support Tool
D.R. Gandara, R. Herbst, T. Mok, S. Ramalingam, K. Obholz, T. Quill, H. Chow, G. Scagliott ( 2017 )
Invited conference paper presented and published in conference proceedings
Clinical significance of 22C3-PD-L1 IHC expression in surgically resected non-small cell lung cancer
Gen Lin, Chao Li, Cheng Huang, Rong Xi Fang, Peng Hai Xu, Dong xian Lin, Biao Wu, Xiaohui Chen, Chunwei Xu, Tony Mok ( 2017 )
Invited conference paper presented and published in conference proceedings
典藏於此文庫的全文:
file.pdf
CNS response to osimertinib in patients (pts) with T790M-positive advanced NSCLC: Data from a randomized phase III trial (AURA3)
Tony Mok, Myung-Ju Ahn, Ji-Youn Han, Jin Hyoung Kang, Nobuyuki Katakami, HyeRyun Kim, Rachel Hodge, Dana C. Ghiorghiu, Mireille Cantarini, Yi-Long Wu, Vassiliki Papadimitrakopoulou, Marina C Garassino ( 2017 )
Invited conference paper presented and published in conference proceedings
典藏於此文庫的全文:
file.pdf

10 | 25 | 50 | 100

1/5

研究成果 (117)

分享連結

Our policy towards the use of cookies